Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1750 of 2529 entries
View as:

Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011

Phase: N/A Priority: Normal
NCT ID: NCT02388620 Org: User:
Start: 03/25/15 End: 01/09/17 Due: 01/09/18

Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).

Phase: N/A Priority: Normal
NCT ID: NCT01682083 Org: User:
Start: 01/08/13 End: 07/31/23 Due: 07/31/24

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg

Phase: N/A Priority: Normal
NCT ID: NCT00687973 Org: User:
Start: 01/31/08 End: 01/31/09 Due: 01/31/10

A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients

Phase: N/A Priority: Normal
NCT ID: NCT03977649 Org: User:
Start: 07/30/19 End: 07/05/21 Due: 07/05/22

Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00669942 Org: User:
Start: 12/31/05 End: 11/30/08 Due: 11/30/09

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00824265 Org: User:
Start: 03/12/09 End: 10/25/17 Due: 10/25/18

Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT02024932 Org: User:
Start: 02/04/14 End: 04/13/16 Due: 04/13/17

Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults

Phase: N/A Priority: Normal
NCT ID: NCT00439738 Org: User:
Start: 12/31/06 End: - Due: -

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Phase: N/A Priority: Normal
NCT ID: NCT01379508 Org: User:
Start: 03/21/11 End: 12/10/15 Due: 12/10/16

STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT00050635 Org: User:
Start: 12/31/02 End: 07/31/03 Due: 07/31/04

Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne

Phase: N/A Priority: Normal
NCT ID: NCT03497897 Org: User:
Start: 09/10/18 End: 03/09/22 Due: 03/09/23

Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)

Phase: N/A Priority: Normal
NCT ID: NCT01534182 Org: User:
Start: 01/31/12 End: 06/30/13 Due: 06/30/14

A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT02925104 Org: User:
Start: 12/14/16 End: 05/16/18 Due: 05/16/19

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00506792 Org: User:
Start: 07/31/07 End: 11/30/09 Due: 11/30/10

Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents

Phase: N/A Priority: Normal
NCT ID: NCT01377012 Org: User:
Start: 08/30/11 End: 09/09/15 Due: 09/09/16

Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02290431 Org: User:
Start: 12/16/14 End: 12/25/18 Due: 12/25/19

Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00425373 Org: User:
Start: 11/30/06 End: 03/31/08 Due: 03/31/09

Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry

Phase: N/A Priority: Normal
NCT ID: NCT06172426 Org: User:
Start: 11/17/22 End: 12/07/22 Due: 12/07/23

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00782067 Org: User:
Start: 10/13/08 End: 08/24/17 Due: 08/24/18

Open-label Extension Study for CLCZ696G2301 (PARADISE-MI)

Phase: N/A Priority: Normal
NCT ID: NCT04637555 Org: User:
Start: 05/26/21 End: 06/01/23 Due: 06/01/24

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

Phase: N/A Priority: Normal
NCT ID: NCT03056755 Org: User:
Start: 08/14/17 End: 11/12/24 Due: 11/12/25

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01785472 Org: User:
Start: 04/30/13 End: 08/31/14 Due: 08/31/15

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00876694 Org: User:
Start: 03/31/09 End: 10/31/10 Due: 10/31/11

Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02125734 Org: User:
Start: 04/30/14 End: 01/31/15 Due: 01/31/16

A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06905327 Org: User:
Start: 03/08/23 End: 08/14/25 Due: 08/14/26